Physicians' Academy for Cardiovascular Education

Understanding the increased CV risk of high Lp(a) levels

10' education - Sep. 28, 2021 - Prof. Florian Kronenberg, MD, PhD - Innsbruck, Austria

Video navigation menu

  • Distribution of Lp(a) concentrations in the general population 00:54
  • Relation between Lp(a) and risk for MI 01:24
  • Genetic basis of Lp(a) 02:53
  • Mendelian randomization studies on Lp(a) 04:43
  • When should Lp(a) be tested? 07:58

Educational information

This lecture by prof. Florian Kronenberg was part of an accredited symposium "Lp(a): from CV risk marker to therapeutic target" held during the virtual ESC Congress 2021.

Faculty

Florian Kronenberg, MD, PhD is full professor and head of the Institute of Genetic Epidemiology at the Medical University of Innsbruck in Austria.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by unrestricted educational grants received from Sanofi and Novartis.

Click here for the meeting report View slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: